NanoViricides, Inc. (NNVC) financial statements (2022 and earlier)

Company profile

Business Address 1 CONTROLS DRIVE
SHELTON, CT 06484
State of Incorp. NV
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17,33620,51713,7092,5557,08215,09924,162
Cash and cash equivalents17,33620,51713,7092,5557,08215,09924,162
Prepaid expense142307277270240190219
Other undisclosed current assets37      
Total current assets:17,51520,82413,9862,8257,32215,29024,382
Noncurrent Assets
Property, plant and equipment8,9459,0859,54410,22710,84111,27111,761
Intangible assets, net (including goodwill)346350358367375383391
Intangible assets, net (excluding goodwill)346350358367375383391
Other undisclosed noncurrent assets442629859100
Total noncurrent assets:9,2949,4399,92910,62311,22411,71312,252
TOTAL ASSETS:26,81030,26223,91413,44918,54627,00336,633
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities177224450379476336299
Accounts payable15320038131022313697
Accrued liabilities242469692533436
Interest and dividends payable     167167
Debt      5,475
Derivative instruments and hedges, liabilities      203
Due to related parties16732562824107341767
Other undisclosed current liabilities 951,1451,6462983,988 
Total current liabilities:3443512,1562,8488824,6666,744
Noncurrent Liabilities
Other undisclosed noncurrent liabilities     2,0156,841
Total noncurrent liabilities:     2,0156,841
Total liabilities:3443512,1562,8488826,68113,585
Stockholders' equity
Stockholders' equity attributable to parent, including:26,46529,91121,75810,60017,66420,32223,048
Common stock1212977696358
Additional paid in capital145,373144,285127,312102,635101,28395,38387,810
Accumulated deficit(118,920)(114,385)(105,563)(92,117)(83,692)(75,129)(64,824)
Other undisclosed stockholders' equity attributable to parent0005544
Total stockholders' equity:26,46529,91121,75810,60017,66420,32223,048
TOTAL LIABILITIES AND EQUITY:26,81030,26223,91413,44918,54627,00336,633

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Operating expenses(8,715)(8,744)(7,996)(8,660)(9,325)(9,601)(8,860)
Operating loss:(8,715)(8,744)(7,996)(8,660)(9,325)(9,601)(8,860)
Nonoperating income (expense)(0)(78)(5,450)235762(704)(1,865)
Other nonoperating income7917551006163
Interest and debt expense(8)(85)(94) (359)(333)(1,042)
Loss from continuing operations before equity method investments, income taxes:(8,723)(8,908)(13,540)(8,424)(8,923)(10,637)(11,767)
Other undisclosed income from continuing operations before income taxes88594 3593331,042
Net loss available to common stockholders, diluted:(8,715)(8,822)(13,447)(8,424)(8,563)(10,304)(10,725)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net loss:(8,715)(8,822)(13,447)(8,424)(8,563)(10,304)(10,725)
Comprehensive loss, net of tax, attributable to parent:(8,715)(8,822)(13,447)(8,424)(8,563)(10,304)(10,725)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: